Watchlist

Watchlist
AngioDynamics, Inc. (ANGO)
AngioDynamics, Inc. (ANGO)
AngioDynamics (ANGO) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more …
Premarket analyst action - healthcare
AmerisourceBergen (NYSE: ABC ) initiated with Outperform rating and $105 (12% upside) price target by Evercore ISI. More news on: AmerisourceBergen Corporation, Arbutus Biopharma Corp, AxoGen, Inc., Healthcare stocks news, Read more …
AngioDynamics' (ANGO) CEO Jim Clemmer on Q2 2018 Results - Earnings Call Transcript
AngioDynamics, Inc. (ANGO) Q2 2018 Earnings Conference Call January 4, 2018, 8:00 AM ET Executives Jim Clemmer - President and CEO Michael Greiner - Executive Vice President and CFO Steve Trowbridge - Senior Vice President, General Counsel Analysts Jason Mills - Canaccord G…
AngioDynamics, Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q2 earnings Read more …
AngioDynamics EPS in-line, misses on revenue
AngioDynamics (NASDAQ: ANGO ): Q2 EPS of $0.16 in-line. More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more …
AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
Fiscal 2018 Second Quarter Highlights Net sales of $86.7 million, a decrease of 2.6% year over year U.S. GAAP EPS of $0.01; Adjusted EPS of $0.16 per share Operating cash flow of $10.2 million; free cash flow of $9.4 million AngioDynamics, Inc.(NASDAQ:ANGO…
Notable earnings before Thursday's open
ANGO , LW , MON , RPM , WBA For Seeking Alpha's full earnings season calendar, click here . More news on: AngioDynamics, Inc., Lamb Weston Holdings, Inc., Monsanto Company, Earnings news and commentary,
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vic…
AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report financial results for the second quarter of fiscal year 2018 before the mar…
AngioDynamics, Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2018 Q1 earnings Read more …
Midday Gainers / Losers
Gainers: AMMA +123% . ZYNE +57% . EXA +43% . BYBK +41% . OTCPK:OMNT +35% . MDGL +33% . ROSE +19% . AQMS +16% . EDIT +18% . SPPI +18% . More news on: Alliance MMA, Zynerba Pharmaceuticals, Exa Corporation, Stocks on the move, Read more …
AngioDynamics, Inc. (ANGO)